Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 301 to 325 of about 5865

Previous 25

Website Changes

05/08/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials Tonight Monday May 8 at 7PM Eastern!

05/07/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials, starts Tonight!

05/04/2023

Clinical trial has promising results to fight brain cancer

05/03/2023

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines

05/02/2023

Join Us for Brain Tumor Awareness Month Webinar Series. Tonight`s topic is Pediatric Brain Tumors!

05/02/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials

04/29/2023

Interstitial photodynamic therapy for newly diagnosed glioblastoma

04/26/2023

Seattle Children’s Launches Pioneering Immunotherapy Clinical Trial Targeting Four Antigens at the Same Time to Combat Pediatric Brain and Spinal Cord Tumors

04/24/2023

Gel has 100% success rate in stopping brain tumors in mice

04/24/2023

The Uncertainty of Clinical Trial Results

04/21/2023

Oblato Announces the First Enrollment in a Phase 1 Clinical Trial for an Oral Formulation of OKN-007 in Recurrent High-Grade Glioma Patients in the USA

04/21/2023

FDA About to Make Drug Approvals More Difficult

04/18/2023

UCLA BRAIN TUMOR CENTER TO HOST 23RD ANNUAL UCLA BRAIN TUMOR CONFERENCE

04/18/2023

Survey for Community Neuro-oncs!

04/14/2023

New TSA Protocol For Optune Users in US Airports

04/13/2023

From Tragedy to Triumph: A Promising New Treatment for Pediatric Brain Cancer

04/11/2023

Special diet triggers self-destruction of brain cancer cells in mice

04/11/2023

Meet actual users and caregivers at an Optune® Open House (Depew, NY)

04/06/2023

Musella Foundation Copay Program now closed to new and renewal patients

04/02/2023

Musella Foundation Copay Program Almost Closed!

03/31/2023

Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial

03/28/2023

Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme

03/28/2023

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5

03/24/2023

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

03/17/2023

FDA Approves Dabrafenib Plus Trametinib for Pediatric BRAF V600E-Mutant Low-Grade Glioma

Our privacy / cookie policy has changed.
Click HERE to read it!